Royalty Pharma plc (RPRX) Adds to IPO Gains
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
Royalty Pharma plc (RPRX) IPO Opens 57% Higher
June 16, 2020 12:07 PM EDTToday's IPO for Royalty Pharma plc (NASDAQ: RPRX) opened for trading at $44 after pricing 77,681,670 shares of its Class A ordinary shares at $28.
The underwriters have a 30-day option to purchase up to an additional 11,652,250 Class A ordinary shares from the company.
J.P. Morgan, Morgan Stanley, BofA Securities, Goldman Sachs & Co. LLC, Citigroup and UBS Investment Bank are acting as joint lead book-running... More



